Maheedhara R. Guda

1.3k total citations
27 papers, 917 citations indexed

About

Maheedhara R. Guda is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Maheedhara R. Guda has authored 27 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Cancer Research and 10 papers in Genetics. Recurrent topics in Maheedhara R. Guda's work include Cancer, Hypoxia, and Metabolism (10 papers), Glioma Diagnosis and Treatment (10 papers) and Mitochondrial Function and Pathology (5 papers). Maheedhara R. Guda is often cited by papers focused on Cancer, Hypoxia, and Metabolism (10 papers), Glioma Diagnosis and Treatment (10 papers) and Mitochondrial Function and Pathology (5 papers). Maheedhara R. Guda collaborates with scholars based in United States, India and Canada. Maheedhara R. Guda's co-authors include Kiran Kumar Velpula, Andrew J. Tsung, Swapna Asuthkar, Collin M. Labak, Ian J. Purvis, Carlen Yuen, Paul Y. Wang, Durbaka V. R. Prasad, Jack A. Tuszyński and Sujatha Venkataraman and has published in prestigious journals such as Cancer Research, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Maheedhara R. Guda

27 papers receiving 909 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maheedhara R. Guda United States 18 488 329 250 245 161 27 917
Jia-Shiun Leu United States 7 367 0.8× 240 0.7× 262 1.0× 141 0.6× 168 1.0× 9 719
Ninib Baryawno Sweden 16 586 1.2× 259 0.8× 213 0.9× 292 1.2× 122 0.8× 35 1.1k
Avadhut D. Joshi United States 15 709 1.5× 449 1.4× 162 0.6× 238 1.0× 436 2.7× 26 1.2k
Álex Cordero United States 15 363 0.7× 233 0.7× 313 1.3× 306 1.2× 107 0.7× 21 845
Samuel K. McBrayer United States 18 778 1.6× 484 1.5× 116 0.5× 196 0.8× 229 1.4× 44 1.2k
Xiaoteng Cui China 19 611 1.3× 386 1.2× 135 0.5× 142 0.6× 142 0.9× 40 932
Nazanin Majd United States 13 337 0.7× 116 0.4× 140 0.6× 192 0.8× 347 2.2× 63 799
Lukas P. Frenzel Germany 19 664 1.4× 225 0.7× 304 1.2× 354 1.4× 299 1.9× 34 1.3k
Melisa J. Hamilton Canada 13 546 1.1× 169 0.5× 692 2.8× 320 1.3× 99 0.6× 14 1.3k
HuiYong Zhao United States 12 584 1.2× 170 0.5× 133 0.5× 426 1.7× 44 0.3× 18 1.1k

Countries citing papers authored by Maheedhara R. Guda

Since Specialization
Citations

This map shows the geographic impact of Maheedhara R. Guda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maheedhara R. Guda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maheedhara R. Guda more than expected).

Fields of papers citing papers by Maheedhara R. Guda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maheedhara R. Guda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maheedhara R. Guda. The network helps show where Maheedhara R. Guda may publish in the future.

Co-authorship network of co-authors of Maheedhara R. Guda

This figure shows the co-authorship network connecting the top 25 collaborators of Maheedhara R. Guda. A scholar is included among the top collaborators of Maheedhara R. Guda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maheedhara R. Guda. Maheedhara R. Guda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guda, Maheedhara R., et al.. (2025). Survivin Interference and SurVaxM as an Adjunct Therapy for Glioblastoma Multiforme. Cells. 14(10). 755–755. 1 indexed citations
2.
Guda, Maheedhara R., Andrew J. Tsung, Swapna Asuthkar, & Kiran Kumar Velpula. (2022). Galectin-1 activates carbonic anhydrase IX and modulates glioma metabolism. Cell Death and Disease. 13(6). 574–574. 10 indexed citations
3.
Guda, Maheedhara R., Swapna Asuthkar, Teluguakula Narasaraju, et al.. (2021). PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis. Biomedicines. 9(12). 1867–1867. 22 indexed citations
4.
Asuthkar, Swapna, et al.. (2020). Beyond glucose: alternative sources of energy in glioblastoma. Theranostics. 11(5). 2048–2057. 44 indexed citations
5.
Guda, Maheedhara R., et al.. (2020). A potential role for Galectin-3 inhibitors in the treatment of COVID-19. PeerJ. 8. e9392–e9392. 66 indexed citations
6.
Purvis, Ian J., Kiran Kumar Velpula, Maheedhara R. Guda, et al.. (2020). B7-H3 in Medulloblastoma-Derived Exosomes; A Novel Tumorigenic Role. International Journal of Molecular Sciences. 21(19). 7050–7050. 28 indexed citations
7.
Guda, Maheedhara R., Collin M. Labak, Swapna Asuthkar, et al.. (2019). GLUT1 and TUBB4 in Glioblastoma Could be Efficacious Targets. Cancers. 11(9). 1308–1308. 37 indexed citations
8.
Purvis, Ian J., Avilala Janardhan, Maheedhara R. Guda, et al.. (2019). Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis. Journal of Clinical Medicine. 8(8). 1158–1158. 43 indexed citations
9.
Guda, Maheedhara R., et al.. (2018). An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.. PubMed. 8(10). 1967–1976. 83 indexed citations
10.
Malchenko, Sergey, Simone Treiger Sredni, Jerusha Boyineni, et al.. (2018). Characterization of brain tumor initiating cells isolated from an animal model of CNS primitive neuroectodermal tumors. Oncotarget. 9(17). 13733–13747. 9 indexed citations
11.
Purvis, Ian J., Maheedhara R. Guda, Sujatha Venkataraman, et al.. (2018). Abstract 512: miR-29 expression regulates B7-H3 mediated angiogenesis in medullablastoma. Cancer Research. 78(13_Supplement). 512–512. 1 indexed citations
12.
Guda, Maheedhara R., Swapna Asuthkar, Collin M. Labak, et al.. (2018). Targeting PDK4 inhibits breast cancer metabolism.. PubMed. 8(9). 1725–1738. 46 indexed citations
13.
Tsung, Andrew J., Maheedhara R. Guda, Swapna Asuthkar, et al.. (2017). Methylation regulates HEY1 expression in glioblastoma. Oncotarget. 8(27). 44398–44409. 25 indexed citations
14.
Price, Neil P. J., Jiakun Li, Kiran Kumar Velpula, et al.. (2017). Modified tunicamycins with reduced eukaryotic toxicity that enhance the antibacterial activity of β-lactams. The Journal of Antibiotics. 70(11). 1070–1077. 23 indexed citations
15.
Agarwal, Pooja, et al.. (2017). Elucidating immunometabolic targets in glioblastoma.. PubMed. 7(10). 1990–1995. 5 indexed citations
16.
Lu, Yining, Collin M. Labak, Neha Jain, et al.. (2017). OTX2 expression contributes to proliferation and progression in Myc-amplified medulloblastoma.. PubMed. 7(3). 647–656. 23 indexed citations
17.
Purvis, Ian J., Collin M. Labak, Maheedhara R. Guda, et al.. (2017). B7-H3 role in the immune landscape of cancer.. PubMed. 6(4). 66–75. 151 indexed citations
18.
Asuthkar, Swapna, Maheedhara R. Guda, Sarah E. Martin, et al.. (2016). Hand1 overexpression inhibits medulloblastoma metastasis. Biochemical and Biophysical Research Communications. 477(2). 215–221. 6 indexed citations
19.
Yuen, Carlen, Swapna Asuthkar, Maheedhara R. Guda, Andrew J. Tsung, & Kiran Kumar Velpula. (2016). Cancer stem cell molecular reprogramming of the Warburg effect in glioblastomas: a new target gleaned from an old concept. CNS Oncology. 5(2). 101–108. 68 indexed citations
20.
Alvarado, Alvaro G., Soumya M. Turaga, Pratheesh Sathyan, et al.. (2015). Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling. Neuro-Oncology. 18(5). 656–666. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026